HK1082426A1 - Softgel of nlkj for treating prostate disease - Google Patents

Softgel of nlkj for treating prostate disease

Info

Publication number
HK1082426A1
HK1082426A1 HK06104117A HK06104117A HK1082426A1 HK 1082426 A1 HK1082426 A1 HK 1082426A1 HK 06104117 A HK06104117 A HK 06104117A HK 06104117 A HK06104117 A HK 06104117A HK 1082426 A1 HK1082426 A1 HK 1082426A1
Authority
HK
Hong Kong
Prior art keywords
nlkj
softgel
treating prostate
prostate disease
value
Prior art date
Application number
HK06104117A
Other languages
English (en)
Inventor
Dapeng Li
Original Assignee
Dapeng Li
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dapeng Li filed Critical Dapeng Li
Publication of HK1082426A1 publication Critical patent/HK1082426A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A61K36/8994—Coix (Job's tears)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK06104117A 2002-09-28 2006-04-04 Softgel of nlkj for treating prostate disease HK1082426A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNA021373116A CN1485072A (zh) 2002-09-28 2002-09-28 治疗前列腺疾病的薏苡仁油软胶囊及其应用
PCT/CN2003/000803 WO2004028549A1 (fr) 2002-09-28 2003-09-22 Capsules de coixenolide destinees au traitement d'une maladie prostatique

Publications (1)

Publication Number Publication Date
HK1082426A1 true HK1082426A1 (en) 2006-06-09

Family

ID=32034732

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06104117A HK1082426A1 (en) 2002-09-28 2006-04-04 Softgel of nlkj for treating prostate disease

Country Status (12)

Country Link
US (1) US8299121B2 (ko)
EP (1) EP1576959B1 (ko)
JP (2) JP4718836B2 (ko)
CN (2) CN1485072A (ko)
AT (1) ATE493140T1 (ko)
AU (1) AU2003272841A1 (ko)
DE (1) DE60335575D1 (ko)
DK (1) DK1576959T3 (ko)
ES (1) ES2358420T3 (ko)
HK (1) HK1082426A1 (ko)
RU (1) RU2296581C2 (ko)
WO (1) WO2004028549A1 (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9492493B2 (en) * 2003-09-22 2016-11-15 Dapeng Li Softgel of NLKJ for treating prostate diseases
BRPI0513677B8 (pt) 2004-07-30 2021-05-25 Exelixis Inc derivados de pirrol como agentes farmacêuticos
CN102511824A (zh) * 2011-12-20 2012-06-27 金利油脂（苏州）有限公司 一种抗突变抗肿瘤的功能性食品
CN105254498B (zh) * 2014-07-18 2017-11-21 浙江康莱特药业有限公司 化合物1,3‑二油酸‑2‑亚油酸甘油酯、制剂、制备方法及其应用
CN105250804A (zh) * 2014-07-18 2016-01-20 浙江康莱特集团有限公司 含有11种甘油三酯的薏苡仁油、制剂及其应用
US9884037B2 (en) * 2014-07-18 2018-02-06 Zhejiang Kanglaite Group Co., Ltd. Pharmaceutical composition containing 8 triglycerides, and preparations and use thereof
CN104173824B (zh) * 2014-07-18 2017-02-15 浙江康莱特集团有限公司 含有8种甘油三酯的薏苡仁油、制剂及其应用
US9585929B2 (en) * 2014-07-18 2017-03-07 Zhejiang Kanglaite Group Co., Ltd. Coix seed oil containing 13 glycerides, and pharmaceutical preparation and use thereof
CN105311486A (zh) * 2014-07-18 2016-02-10 浙江康莱特集团有限公司 含有16种甘油酯的薏苡仁油、制剂及其应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5731604A (en) * 1980-07-31 1982-02-20 Okayasu Shoten:Kk Skin cosmetic
JPS58213719A (ja) * 1982-06-02 1983-12-12 Yasuo Araki 薬物的活性剤
JPS58210022A (ja) * 1982-06-02 1983-12-07 Yasuo Araki ハトムギ有効成分の純品精出法及び定量検定法
JPH01186815A (ja) * 1988-01-21 1989-07-26 Tokai Kapuseru Kk 軟カプセル剤およびその製造法
JPH02240019A (ja) * 1989-03-13 1990-09-25 Daicel Chem Ind Ltd 抗発癌プロモーター
JP2783848B2 (ja) * 1989-07-04 1998-08-06 晟 八木 新規ホスファチジルコリンカルシウムとその製法
CN1031261C (zh) * 1991-10-21 1996-03-13 中国科学院大连化学物理研究所 一种薏苡仁酯的提取方法
CA2125888C (en) * 1992-01-06 2002-08-27 Harry B. Demopoulos Pharmaceutically active antioxidant containing composition and the method of its use to prevent and treat restenosis following angioplasty
PH30249A (en) * 1992-09-16 1997-02-05 Zhejiang Provincial Hospital O Neutral lipids from endosperm of job's tears
CN1070680A (zh) * 1992-09-17 1993-04-07 李大鹏 薏苡仁中性油脂提取方法
CN1029662C (zh) 1992-09-17 1995-09-06 李大鹏 薏苡仁中性油脂及其提取方法
JPH06247858A (ja) * 1993-02-23 1994-09-06 Fujimoto Seiyaku Kk 慢性腎不全における抗骨異栄養症剤
JPH07115942A (ja) * 1993-08-09 1995-05-09 Sanji Kumai 生薬オリゴドリンク及び生薬オリゴゼリーの製造法
CN1064244C (zh) * 1993-11-09 2001-04-11 中国科学院大连化学物理研究所 中药薏苡仁提取物在制备治疗红班角化症、鳞状毛囊角化症、红皮症药物中的应用
US20010002269A1 (en) * 1997-05-06 2001-05-31 Zhao Iris Ginron Multi-phase food & beverage
CN1075378C (zh) * 1997-09-30 2001-11-28 陈金义 一种抗肿瘤的中药乳剂及其制备方法
EP1102593B1 (en) * 1998-08-03 2007-11-14 Ronald E. Wheeler Prostate formula
US6565874B1 (en) * 1998-10-28 2003-05-20 Atrix Laboratories Polymeric delivery formulations of leuprolide with improved efficacy
JP3983003B2 (ja) * 2001-03-15 2007-09-26 株式会社ファンケル グルタチオン増強用組成物
US20030236301A1 (en) * 2001-12-19 2003-12-25 Bob Sanders Liposomal delivery of vitamin E based compounds
CN1440782A (zh) * 2003-03-28 2003-09-10 沈阳药科大学 一种含有薏苡仁油及鸦胆子油复合纳米乳剂的制备工艺及配方

Also Published As

Publication number Publication date
CN1684697A (zh) 2005-10-19
RU2296581C2 (ru) 2007-04-10
CN1301128C (zh) 2007-02-21
DE60335575D1 (de) 2011-02-10
ATE493140T1 (de) 2011-01-15
CN1485072A (zh) 2004-03-31
JP4718836B2 (ja) 2011-07-06
US8299121B2 (en) 2012-10-30
US20100137427A9 (en) 2010-06-03
EP1576959B1 (en) 2010-12-29
DK1576959T3 (da) 2011-03-28
EP1576959A1 (en) 2005-09-21
AU2003272841A1 (en) 2004-04-19
US20050222249A1 (en) 2005-10-06
WO2004028549A1 (fr) 2004-04-08
ES2358420T3 (es) 2011-05-10
RU2005112775A (ru) 2006-11-10
EP1576959A4 (en) 2008-04-23
JP2011016852A (ja) 2011-01-27
JP2006502193A (ja) 2006-01-19

Similar Documents

Publication Publication Date Title
HK1082426A1 (en) Softgel of nlkj for treating prostate disease
TWI265809B (en) Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
EA200001044A3 (ru) Соединения для лечения женской сексуальной дисфункции
BRPI0507039A8 (pt) composição, métodos de tratar um paciente com câncer, e de inibir a angiogênese em um tumor, e, kit
SG156640A1 (en) Pyrazole or triazole compounds and their use for the manufacture of a medicament for treating somatic mutation-related diseases
NZ709704A (en) Protein formulations and methods of making same
AU2001225434A1 (en) Lens implant
DE60026538D1 (de) Pharmazeutische zubereitungen die clavulansäure oder derivate enthalten zur behandlund von neurologischen störungen
WO1997048391A3 (en) Methods and compositions comprising r-ibuprofen
BR0009718A (pt) Processo de tratamento
HK1103363A1 (en) Treatment of glycogen storage diseases type ii ii
IL159205A0 (en) Carbocyclic hydrazino inhibitors of copper-containing amine oxidases
MXPA05004697A (es) Soluciones farmaceuticas que comprenden un compuesto modafinil y uso para la fabricacion de un medicamento para tratar diferentes enfermedades.
GEP20043367B (en) N-[5-[[[5-Alkyl-2-Oxazolyl]Methyl]Thio]-2-Thiazolyl Carboxamide Inhibitors of Cyclin Dependent Kinases
AU2002218311A1 (en) Farnesyl protein transferase inhibitors for the treatment of inflammatory bowel disease
MXPA03000188A (es) Metodo de tratamiento de enfermedades relacionadas con neutroficos con anestesicos locales.
GB2456475A (en) Composition for the treatment of skin conditions
NZ522242A (en) Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
NZ528164A (en) Use of flumazenil to produce a medicament for the treatment of cocaine dependency
CN204352371U (zh) 一种口腔科用给药装置
AP2004003177A0 (en) Composition and its therapeutic use
MX2022006083A (es) Metodos para tratar afecciones relacionadas con el receptor s1p1.
ATE381930T1 (de) Kombinationsmedikationen mit einem selektiven cyclooxygenase-2-inhibitor
EA200400461A1 (ru) Применение экстрактов из растений семейства cimicifuga в качестве медикамента для лечения нарушений мочеполового тракта, связанных с половыми гормонами
MXPA05012696A (es) Formulaciones de agentes antiinflamatorios no esteroides para tratar angiogenesis ocular patologica.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200924